{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:03:15Z","timestamp":1790960595642,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>SARS-CoV-2 infection affects multiple immune mechanisms and leads to severe COVID-19 and death, in part related to infection-induced or pre-existing autoantibodies. Here, we describe severe COVID-19 to associate with autoantibodies against interleukin-1 receptor antagonist (IL-1Ra) and progranulin (PGRN), endogenous antagonists of IL-1 and TNF signaling, respectively. These autoantibodies coincide with hyperphosphorylation of IL-1Ra (Thr111) or PGRN (Ser81), form immune complexes independent of phosphorylation, reduce antigen plasma levels, and permit enhanced IL-1 and TNF signaling. Using phage-display selected Fabs specific for hyperphosphorylated isoforms, we track phospho-antigens and autoantibodies in a German national pandemic network cohort. Most seropositive patients show both autoantibodies. Levels peak at baseline and decline over 12 months, with phospho-antigens decreasing before autoantibodies. Seropositivity associates with hyperinflammation and cytokine profiles. Importantly, signaling by key inflammatory cytokines induce IL-1Ra and PGRN hyperphosphorylation in healthy monocytes, but require up to 1000-fold higher doses than in monocytes from previously seropositive severe COVID-19 survivors.<\/jats:p>","DOI":"10.1038\/s41467-026-73316-5","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:55:14Z","timestamp":1779900914000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8167-2989","authenticated-orcid":false,"given":"Lorenz","family":"Thurner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Fadle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Thurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor Age","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Bewarder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evi","family":"Regitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Bette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvan","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Lesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Rixecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christin","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-Dieter","family":"Preuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Kaddu-Mulindwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Roemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3441-7743","authenticated-orcid":false,"given":"Onur","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Mang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9422-6569","authenticated-orcid":false,"given":"Christian","family":"Herr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Lensch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Thiel-Bodenstaff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Werner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Wuchter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sixten","family":"K\u00f6rper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Pfuhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2529-1900","authenticated-orcid":false,"given":"Stefan","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Rissland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Thieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Pilch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cihan","family":"Papan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5446-7170","authenticated-orcid":false,"given":"J. Janne","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarete","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2471-9456","authenticated-orcid":false,"given":"Isabel","family":"Br\u00f6hl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9787-5633","authenticated-orcid":false,"given":"Martin","family":"Witzenrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Thibeault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira an","family":"Haack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazar","family":"Mitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina M.","family":"P\u00fctz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens-Peter","family":"Reese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Krawczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckard","family":"Hamelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Kopfnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Fiedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramsia","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike","family":"Valentin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Han\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3095-8362","authenticated-orcid":false,"given":"Sabine","family":"Ameling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5689-3448","authenticated-orcid":false,"given":"Uwe","family":"V\u00f6lker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Hansch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8800-7554","authenticated-orcid":false,"given":"Sabine","family":"Blaschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Braunsteiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Dahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Petersmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6830-9296","authenticated-orcid":false,"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0767-7941","authenticated-orcid":false,"given":"Frank","family":"Bloos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Schrezenmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Langer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gereon","family":"G\u00e4belein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Friesenhahn-Ochs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1673-6285","authenticated-orcid":false,"given":"Jochen","family":"Pfeifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1521-3514","authenticated-orcid":false,"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-8802","authenticated-orcid":false,"given":"S\u00f6ren Leif","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2976-2514","authenticated-orcid":false,"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0483-892X","authenticated-orcid":false,"given":"Gabriele","family":"Anton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Kuenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soni Savai","family":"Pullamsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1495-9530","authenticated-orcid":false,"given":"Mario","family":"Looso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3289-6545","authenticated-orcid":false,"given":"Sigrun","family":"Smola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Meybohm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0113-0777","authenticated-orcid":false,"given":"Marcin","family":"Krawczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp M.","family":"Lepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0638-2949","authenticated-orcid":false,"given":"Christoph","family":"Kessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"73316_CR1","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann, M. et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N. Engl. J. Med 383, 120\u2013128 (2020).","journal-title":"N. Engl. J. Med"},{"key":"73316_CR2","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen, G. et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest 130, 2620\u20132629 (2020).","journal-title":"J. Clin. Invest"},{"key":"73316_CR3","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/art.41285","volume":"72","author":"LA Henderson","year":"2020","unstructured":"Henderson, L. A. et al. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 72, 1059\u20131063 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"73316_CR4","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/art.41763","volume":"73","author":"C Kessel","year":"2021","unstructured":"Kessel, C. et al. Discrimination of COVID-19 from inflammation-induced cytokine storm syndromes using disease-related blood biomarkers. Arthritis Rheumatol. 73, 1791\u20131799 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"73316_CR5","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395, 1033\u20131034 (2020).","journal-title":"Lancet"},{"key":"73316_CR6","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.immuni.2020.06.024","volume":"53","author":"C Schultheiss","year":"2020","unstructured":"Schultheiss, C. et al. Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease. Immunity 53, 442\u2013455 (2020).","journal-title":"Immunity"},{"key":"73316_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s11239-020-02182-9","volume":"50","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients. J. Thromb. Thrombolysis 50, 580\u2013586 (2020).","journal-title":"J. Thromb. Thrombolysis"},{"key":"73316_CR8","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1007\/s10067-020-05359-y","volume":"39","author":"H Fujii","year":"2020","unstructured":"Fujii, H. et al. High levels of anti-SSA\/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review: high levels of anti-SSA\/Ro antibodies in COVID-19. Clin. Rheumatol. 39, 3171\u20133175 (2020).","journal-title":"Clin. Rheumatol."},{"key":"73316_CR9","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1007\/s10067-021-05580-3","volume":"40","author":"A Cristiano","year":"2021","unstructured":"Cristiano, A., Fortunati, V., Cherubini, F., Bernardini, S. & Nuccetelli, M. Anti-phospholipids antibodies and immune complexes in COVID-19 patients: a putative role in disease course for anti-annexin-V antibodies. Clin. Rheumatol. 40, 2939\u20132945 (2021).","journal-title":"Clin. Rheumatol."},{"key":"73316_CR10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41586-021-03631-y","volume":"595","author":"EY Wang","year":"2021","unstructured":"Wang, E. Y. et al. Diverse functional autoantibodies in patients with COVID-19. Nature 595, 283\u2013288 (2021).","journal-title":"Nature"},{"key":"73316_CR11","unstructured":"Bastard P., et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, 4585 (2020)."},{"key":"73316_CR12","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"73316_CR13","doi-asserted-by":"publisher","first-page":"eabd1554","DOI":"10.1126\/sciimmunol.abd1554","volume":"5","author":"JS Lee","year":"2020","unstructured":"Lee, J. S. et al. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19. Sci. Immunol. 5, eabd1554 (2020).","journal-title":"Sci. Immunol."},{"key":"73316_CR14","doi-asserted-by":"publisher","first-page":"e20240365","DOI":"10.1084\/jem.20240365","volume":"221","author":"S Fernbach","year":"2024","unstructured":"Fernbach, S. et al. Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies. J. Exp. Med. 221, e20240365 (2024).","journal-title":"J. Exp. Med."},{"key":"73316_CR15","doi-asserted-by":"publisher","first-page":"e2200413119","DOI":"10.1073\/pnas.2200413119","volume":"119","author":"J Manry","year":"2022","unstructured":"Manry, J. et al. The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies. Proc. Natl. Acad. Sci. USA 119, e2200413119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73316_CR16","doi-asserted-by":"publisher","first-page":"e318","DOI":"10.1093\/infdis\/jiae036","volume":"230","author":"B Strunz","year":"2024","unstructured":"Strunz, B. et al. Type I interferon autoantibodies correlate with cellular immune alterations in severe COVID-19. J. Infect. Dis. 230, e318\u2013e326 (2024).","journal-title":"J. Infect. Dis."},{"key":"73316_CR17","doi-asserted-by":"publisher","first-page":"e163150","DOI":"10.1172\/jci.insight.163150","volume":"8","author":"A Feng","year":"2023","unstructured":"Feng, A. et al. Autoantibodies are highly prevalent in non-SARS-CoV-2 respiratory infections and critical illness. JCI Insight 8, e163150 (2023).","journal-title":"JCI Insight"},{"key":"73316_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10875-023-01642-0","volume":"44","author":"MC Hoffmann","year":"2024","unstructured":"Hoffmann, M. C. et al. Autoantibody-mediated depletion of IL-1RA in still's disease and potential impact of IL-1 targeting therapies. J. Clin. Immunol. 44, 45 (2024).","journal-title":"J. Clin. Immunol."},{"key":"73316_CR19","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.1016\/S2665-9913(22)00064-9","volume":"4","author":"J Pfeifer","year":"2022","unstructured":"Pfeifer, J. et al. Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study. Lancet Rheumatol. 4, e329\u2013e337 (2022).","journal-title":"Lancet Rheumatol."},{"key":"73316_CR20","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJMc2205667","volume":"387","author":"L Thurner","year":"2022","unstructured":"Thurner, L. et al. IL-1RA antibodies in myocarditis after SARS-CoV-2 vaccination. N. Engl. J. Med. 387, 1524\u20131527 (2022).","journal-title":"N. Engl. J. Med."},{"key":"73316_CR21","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.jaci.2021.05.002","volume":"149","author":"JA Jarrell","year":"2022","unstructured":"Jarrell, J. A. et al. Neutralizing anti-IL-1 receptor antagonist autoantibodies induce inflammatory and fibrotic mediators in IgG4-related disease. J. Allergy Clin. Immunol. 149, 358\u2013368 (2022).","journal-title":"J. Allergy Clin. Immunol."},{"key":"73316_CR22","doi-asserted-by":"publisher","first-page":"e92743","DOI":"10.1371\/journal.pone.0092743","volume":"9","author":"C Liu","year":"2014","unstructured":"Liu, C., Li, X. X., Gao, W., Liu, W. & Liu, D. S. Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity. PLoS One 9, e92743 (2014).","journal-title":"PLoS One"},{"key":"73316_CR23","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1126\/science.1199214","volume":"332","author":"W Tang","year":"2011","unstructured":"Tang, W. et al. The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science 332, 478\u2013484 (2011).","journal-title":"Science"},{"key":"73316_CR24","doi-asserted-by":"publisher","first-page":"540794","DOI":"10.1155\/2012\/540794","volume":"2012","author":"Z Guo","year":"2012","unstructured":"Guo, Z. et al. Prevention of LPS-induced acute lung injury in mice by progranulin. Mediators Inflamm. 2012, 540794 (2012).","journal-title":"Mediators Inflamm."},{"key":"73316_CR25","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1016\/j.febslet.2013.04.037","volume":"587","author":"YP Zhao","year":"2013","unstructured":"Zhao, Y. P., Tian, Q. Y. & Liu, C. J. Progranulin deficiency exaggerates, whereas progranulin-derived Atsttrin attenuates, severity of dermatitis in mice. FEBS Lett. 587, 1805\u20131810 (2013).","journal-title":"FEBS Lett."},{"key":"73316_CR26","doi-asserted-by":"crossref","unstructured":"Chen Y. Q., et al. Progranulin improves acute lung injury through regulating the differentiation of regulatory T cells and interleukin-10 immunomodulation to promote macrophage polarization. Mediat. Inflamm. 2020, 9704327 (2020).","DOI":"10.1155\/2020\/9704327"},{"key":"73316_CR27","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/jcmm.12756","volume":"20","author":"Y Yu","year":"2016","unstructured":"Yu, Y. et al. Progranulin deficiency leads to severe inflammation, lung injury and cell death in a mouse model of endotoxic shock. J. Cell Mol. Med. 20, 506\u2013517 (2016).","journal-title":"J. Cell Mol. Med."},{"key":"73316_CR28","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1016\/j.febslet.2013.09.024","volume":"587","author":"J Jian","year":"2013","unstructured":"Jian, J. et al. Progranulin directly binds to the CRD2 and CRD3 of TNFR extracellular domains. FEBS Lett. 587, 3428\u20133436 (2013).","journal-title":"FEBS Lett."},{"key":"73316_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jaut.2015.05.002","volume":"61","author":"L Thurner","year":"2015","unstructured":"Thurner, L. et al. The molecular basis for development of proinflammatory autoantibodies to progranulin. J. Autoimmun. 61, 17\u201328 (2015).","journal-title":"J. Autoimmun."},{"key":"73316_CR30","first-page":"94","volume":"38","author":"G Assmann","year":"2020","unstructured":"Assmann, G. et al. Progranulin-autoantibodies in sera of rheumatoid arthritis patients negative for rheumatoid factor and anti-citrullinated peptide antibodies. Clin. Exp. Rheumatol. 38, 94\u201398 (2020).","journal-title":"Clin. Exp. Rheumatol."},{"key":"73316_CR31","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/iid3.270","volume":"7","author":"P Klemm","year":"2019","unstructured":"Klemm, P. et al. Progranulin autoantibodies in systemic sclerosis and autoimmune connective tissue disorders: a preliminary study. Immun. Inflamm. Dis. 7, 271\u2013275 (2019).","journal-title":"Immun. Inflamm. Dis."},{"key":"73316_CR32","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s10620-014-3089-3","volume":"59","author":"L Thurner","year":"2014","unstructured":"Thurner, L. et al. Proinflammatory progranulin antibodies in inflammatory bowel diseases. Dig. Dis. Sci. 59, 1733\u20131742 (2014).","journal-title":"Dig. Dis. Sci."},{"key":"73316_CR33","doi-asserted-by":"publisher","first-page":"R211","DOI":"10.1186\/ar4406","volume":"15","author":"L Thurner","year":"2013","unstructured":"Thurner, L. et al. Progranulin antibodies entertain a proinflammatory environment in a subgroup of patients with psoriatic arthritis. Arthritis Res Ther. 15, R211 (2013).","journal-title":"Arthritis Res Ther."},{"key":"73316_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaut.2012.10.003","volume":"42","author":"L Thurner","year":"2013","unstructured":"Thurner, L. et al. Progranulin antibodies in autoimmune diseases. J. Autoimmun. 42, 29\u201338 (2013).","journal-title":"J. Autoimmun."},{"key":"73316_CR35","doi-asserted-by":"crossref","unstructured":"Elbert M., et al. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas. Sci. Rep. 14, 9571 (2024).","DOI":"10.1038\/s41598-024-60169-5"},{"key":"73316_CR36","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.3324\/haematol.2019.241653","volume":"106","author":"L Thurner","year":"2021","unstructured":"Thurner, L. et al. Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma. Haematologica 106, 2224\u20132232 (2021).","journal-title":"Haematologica"},{"key":"73316_CR37","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1182\/blood-2018-03-836932","volume":"132","author":"L Thurner","year":"2018","unstructured":"Thurner, L. et al. Hyper-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma. Blood 132, 2744\u20132753 (2018).","journal-title":"Blood"},{"key":"73316_CR38","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/S1470-2045(09)70234-7","volume":"10","author":"S Grass","year":"2009","unstructured":"Grass, S. et al. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study. Lancet Oncol. 10, 950\u2013956 (2009).","journal-title":"Lancet Oncol."},{"key":"73316_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53356-5","volume":"15","author":"AF Jernbom","year":"2024","unstructured":"Jernbom, A. F. et al. Prevalent and persistent new-onset autoantibodies in mild to severe COVID-19. Nat. Commun. 15, 8941 (2024).","journal-title":"Nat. Commun."},{"key":"73316_CR40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41590-023-01445-w","volume":"24","author":"J Muri","year":"2023","unstructured":"Muri, J. et al. Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course. Nat. Immunol. 24, 604\u2013611 (2023).","journal-title":"Nat. Immunol."},{"key":"73316_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36686-8","volume":"14","author":"JR Jaycox","year":"2023","unstructured":"Jaycox, J. R., Lucas, C., Yildirim, I., Dai, Y. & Wang, E. Y. Monteiro V, et al. SARS-CoV-2 mRNA vaccines decouple anti-viral immunity from humoral autoimmunity. Nat. Commun. 14, 1299 (2023).","journal-title":"Nat. Commun."},{"key":"73316_CR42","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.122.061025","volume":"147","author":"LM Yonker","year":"2023","unstructured":"Yonker, L. M. et al. Circulating Spike Protein Detected in Post-COVID-19 mRNA Vaccine Myocarditis. Circulation 147, 867\u2013876 (2023).","journal-title":"Circulation"},{"key":"73316_CR43","doi-asserted-by":"publisher","first-page":"eadh3455","DOI":"10.1126\/sciimmunol.adh3455","volume":"8","author":"A Barmada","year":"2023","unstructured":"Barmada, A. et al. Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditis. Sci. Immunol. 8, eadh3455 (2023).","journal-title":"Sci. Immunol."},{"key":"73316_CR44","doi-asserted-by":"publisher","unstructured":"Rackaityte Eea. Autoantibodies in maternal serum predict spontaneous preterm delivery. medRxiv, https:\/\/doi.org\/10.1101\/2024100324314850 2024.","DOI":"10.1101\/2024100324314850"},{"key":"73316_CR45","doi-asserted-by":"publisher","first-page":"e70039","DOI":"10.1111\/sji.70039","volume":"102","author":"A Behere","year":"2025","unstructured":"Behere, A. et al. Evaluating IL1RA-autoantibodies across SARS-CoV-2-related diseases. Scand. J. Immunol. 102, e70039 (2025).","journal-title":"Scand. J. Immunol."},{"key":"73316_CR46","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41586-024-07722-4","volume":"632","author":"A Bodansky","year":"2024","unstructured":"Bodansky, A. et al. Molecular mimicry in multisystem inflammatory syndrome in children. Nature 632, 622\u2013629 (2024).","journal-title":"Nature"},{"key":"73316_CR47","first-page":"105","volume":"25","author":"J Tate","year":"2004","unstructured":"Tate, J. & Ward, G. Interferences in immunoassay. Clin. Biochem. Rev. 25, 105\u2013120 (2004).","journal-title":"Clin. Biochem. Rev."},{"key":"73316_CR48","doi-asserted-by":"publisher","first-page":"2918","DOI":"10.1182\/blood-2010-09-306076","volume":"117","author":"S Grass","year":"2011","unstructured":"Grass, S. et al. Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia. Blood 117, 2918\u20132923 (2011).","journal-title":"Blood"},{"key":"73316_CR49","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1002\/ijc.28864","volume":"135","author":"KD Preuss","year":"2014","unstructured":"Preuss, K. D., Fadle, N., Regitz, E., Held, G. & Pfreundschuh, M. Inactivation of protein-phosphatase 2\u2009A causing hyperphosphorylation of autoantigenic paraprotein targets in MGUS\/MM is due to an exchange of its regulatory subunits. Int. J. Cancer 135, 2046\u20132053 (2014).","journal-title":"Int. J. Cancer"},{"key":"73316_CR50","doi-asserted-by":"publisher","first-page":"3340","DOI":"10.1182\/blood-2011-04-351668","volume":"118","author":"KD Preuss","year":"2011","unstructured":"Preuss, K. D. et al. Hyperphosphorylation of autoantigenic targets of paraproteins is due to inactivation of PP2A. Blood 118, 3340\u20133346 (2011).","journal-title":"Blood"},{"key":"73316_CR51","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1002\/ijc.29478","volume":"137","author":"F Neumann","year":"2015","unstructured":"Neumann, F. et al. CD4(\u2009+\u2009) T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenstrom's macroglobulinemia. Int J. Cancer 137, 1076\u20131084 (2015).","journal-title":"Int J. Cancer"},{"key":"73316_CR52","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1021\/pr800937k","volume":"8","author":"VS Meyer","year":"2009","unstructured":"Meyer, V. S. et al. Identification of natural MHC class II presented phosphopeptides and tumor-derived MHC class I phospholigands. J. Proteome Res. 8, 3666\u20133674 (2009).","journal-title":"J. Proteome Res."},{"key":"73316_CR53","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1038\/ni.1660","volume":"9","author":"F Mohammed","year":"2008","unstructured":"Mohammed, F. et al. Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self. Nat. Immunol. 9, 1236\u20131243 (2008).","journal-title":"Nat. Immunol."},{"key":"73316_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39734-5","volume":"14","author":"JH Lam","year":"2023","unstructured":"Lam, J. H. & Baumgarth, N. Toll-like receptor mediated inflammation directs B cells towards protective antiviral extrafollicular responses. Nat. Commun. 14, 3979 (2023).","journal-title":"Nat. Commun."},{"key":"73316_CR55","doi-asserted-by":"publisher","first-page":"112630","DOI":"10.1016\/j.celrep.2023.112630","volume":"42","author":"H Allard-Chamard","year":"2023","unstructured":"Allard-Chamard, H. et al. Extrafollicular IgD(-)CD27(-)CXCR5(-)CD11c(-) DN3 B cells infiltrate inflamed tissues in autoimmune fibrosis and in severe COVID-19. Cell Rep. 42, 112630 (2023).","journal-title":"Cell Rep."},{"key":"73316_CR56","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1172\/jci.insight.150107","volume":"6","author":"AN Donlan","year":"2021","unstructured":"Donlan, A. N. et al. IL-13 is a driver of COVID-19 severity. JCI Insight 6, 15 (2021).","journal-title":"JCI Insight"},{"key":"73316_CR57","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1016\/j.cell.2024.04.009","volume":"187","author":"M Momenilandi","year":"2024","unstructured":"Momenilandi, M. et al. FLT3L governs the development of partially overlapping hematopoietic lineages in humans and mice. Cell 187, 2817\u201337 e31 (2024).","journal-title":"Cell"},{"key":"73316_CR58","doi-asserted-by":"publisher","first-page":"e144455","DOI":"10.1172\/jci.insight.144455","volume":"6","author":"MS Abers","year":"2021","unstructured":"Abers, M. S. et al. An immune-based biomarker signature is associated with mortality in COVID-19 patients. JCI Insight 6, e144455 (2021).","journal-title":"JCI Insight"},{"key":"73316_CR59","doi-asserted-by":"publisher","first-page":"105608","DOI":"10.1016\/j.isci.2022.105608","volume":"25","author":"J Klingler","year":"2022","unstructured":"Klingler, J. et al. Immune profiles distinguish hospitalized versus ambulatory. COVID-19 cases older patients.  iScience 25, 105608 (2022).","journal-title":"iScience"},{"key":"73316_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12014-022-09377-7","volume":"19","author":"F Ciccosanti","year":"2022","unstructured":"Ciccosanti, F. et al. Proteomic analysis identifies a signature of disease severity in the plasma of COVID-19 pneumonia patients associated to neutrophil, platelet and complement activation. Clin. Proteom. 19, 38 (2022).","journal-title":"Clin. Proteom."},{"key":"73316_CR61","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1182\/blood.2020007214","volume":"136","author":"BK Manne","year":"2020","unstructured":"Manne, B. K. et al. Platelet gene expression and function in patients with COVID-19. Blood 136, 1317\u20131329 (2020).","journal-title":"Blood"},{"key":"73316_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00899-1","volume":"11","author":"N Yatim","year":"2021","unstructured":"Yatim, N. et al. Platelet activation in critically ill COVID-19 patients. Ann. Intensive Care 11, 113 (2021).","journal-title":"Ann. Intensive Care"},{"key":"73316_CR63","doi-asserted-by":"publisher","first-page":"e2536691","DOI":"10.1001\/jamanetworkopen.2025.36691","volume":"8","author":"MA Wu","year":"2025","unstructured":"Wu, M. A. et al. IL-1 Receptor Antagonist Antibodies in Idiopathic Recurrent Pericarditis. JAMA Netw. Open 8, e2536691 (2025).","journal-title":"JAMA Netw. Open"},{"key":"73316_CR64","doi-asserted-by":"publisher","first-page":"18218","DOI":"10.1074\/jbc.274.26.18218","volume":"274","author":"HJ de Haard","year":"1999","unstructured":"de Haard, H. J. et al. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J. Biol. Chem. 274, 18218\u201318230 (1999).","journal-title":"J. Biol. Chem."},{"key":"73316_CR65","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"73316_CR66","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"73316_CR67","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"},{"key":"73316_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"73316_CR69","first-page":"1","volume":"25","author":"JJ S\u00e9bastien L\u00ea","year":"2008","unstructured":"S\u00e9bastien L\u00ea, J. J. Fran\u00e7ois Husson FactoMineR: an R package for multivariate analysis. J. Stat. Softw. 25, 1\u201318 (2008).","journal-title":"J. Stat. Softw."},{"key":"73316_CR70","doi-asserted-by":"publisher","first-page":"W316","DOI":"10.1093\/nar\/gkr483","volume":"39","author":"C Xie","year":"2011","unstructured":"Xie, C. et al. KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases. Nucleic Acids Res. 39, W316\u2013W322 (2011).","journal-title":"Nucleic Acids Res."},{"key":"73316_CR71","unstructured":"Gennady Korotkevich V. S., Nikolay Budin, Boris Shpak, Maxim N. Artyomov, Alexey Sergushichev. Fast gene set enrichment analysis. bioRxiv. 2021."},{"key":"73316_CR72","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73316_CR73","doi-asserted-by":"publisher","first-page":"W247","DOI":"10.1093\/nar\/gkp464","volume":"37","author":"F Zambelli","year":"2009","unstructured":"Zambelli, F., Pesole, G. & Pavesi, G. Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes. Nucleic Acids Res 37, W247\u2013W252 (2009).","journal-title":"Nucleic Acids Res"},{"key":"73316_CR74","doi-asserted-by":"publisher","first-page":"D165","DOI":"10.1093\/nar\/gkab1113","volume":"50","author":"JA Castro-Mondragon","year":"2022","unstructured":"Castro-Mondragon, J. A. et al. JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles. Nucleic Acids Res. 50, D165\u2013D173 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73316-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73316-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73316-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T10:03:15Z","timestamp":1779962595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73316-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73316"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73316-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Statement The University of Saarland with Lorenz Thurner, Klaus-Dieter Preuss and Michael Pfreundschuh as investigators had applied for a patent on the role of PGRN as a marker for autoimmunity in 2012. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4768"}}